Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

"Six-week Study of the Safety and Efficacy of JZP-110 in the Treatment of Excessive Sleepiness in OSA"

ClinicalTrials.gov ID: NCT02348619

Public ClinicalTrials.gov record NCT02348619. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 22, 2026, 4:28 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Six-Week, Double-Blind, Placebo-Controlled, Randomized- Withdrawal, Multicenter Study of the Safety and Efficacy of JZP-110 [(R)-2-amino-3-phenylpropylcarbamate Hydrochloride] in the Treatment of Excessive Sleepiness in Subjects With Obstructive Sleep Apnea (OSA)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This trial is a 6-week, double-blind, placebo-controlled, randomized-withdrawal, multicenter study of safety and efficacy of JZP-110 in the treatment of excessive sleepiness in adult subjects with OSA.

Study identification

NCT ID
NCT02348619
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Jazz Pharmaceuticals
Industry
Enrollment
174 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years to 75 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 2015 (Type not available)
Primary completion
Nov 2016 (Actual)
Completion
Nov 2016 (Actual)
Last update posted
Sep 9, 2019

2015 – 2016

United States locations

U.S. sites
22
U.S. states
13
U.S. cities
21
Facility City State ZIP Site status
Sleep Disorder Center of Alabama Birmingham Alabama 35213 —
The Research Center of Southern California Oceanside California 92056 —
SDS Clinical Trials, INC Orange California 92868 —
Santa Monica Clinical Trials Santa Monica California 90404 —
Critical Care Pulmonary & Sleep Associates, LLC Lakewood Colorado 80228 —
PAB Clinical Research Brandon Florida 33511 —
Broward Research Group, Inc. Hollywood Florida 33024 —
Oviedo Medical Research, LLC Oviedo Florida 32765 —
Emory Sleep Center Atlanta Georgia 30329 —
Rowe Neurology Institute RNI - Lenexa Lenexa Kansas 66214 —
Veritas Clinical Specialities LTD Topeka Kansas 66606 —
Advanced Neurodiagnostic Ceneter Metairie Louisiana 70006 —
Johns Hopkins Hospital Baltimore Maryland 21224 —
Brigham & Womens Hospital Boston Massachusetts 02115 —
Duke University Medical Center Durham North Carolina 27710 —
PMG Research of Wilmington Wilmington North Carolina 28401 —
Center for Sleep & Circadian Neurobiology Philadelphia Pennsylvania 19104 —
UPMC Sleep Medicine Center Pittsburgh Pennsylvania 15213 —
Lowcountry Lung Critical Care Charleston South Carolina 29406 —
Medical University of South Carolina Charleston South Carolina 29425 —
EVMS Sleep Medicine Norfolk Virginia 23510 —
American Sleep Medicine Vienna Virginia 22182 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 8 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02348619, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Sep 9, 2019 · Synced Oct 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT02348619 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →